Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.

Trials - 21 Apr 2010

Ozolins Mara, Williams Hywel C, Armstrong Sarah J, Bath-Hextall Fiona J

Abstract excerpt

BACKGROUND: Basal cell carcinoma is the commonest human cancer. Despite increasing incidence it remains poorly researched. While not life threatening it can cause significant cosmetic disfigurement. Imiquimod, a cream which enhances the body's immune response, may help deal with the number of cas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Cutaneous
Share to Aminoquinolines
Share to Carcinoma, Basal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to Drug Costs

Share to Health Care Costs

Share to Patient Satisfaction

Share to Research Design

Source

Open in PubMed Open full text

Identifiers

PMID: 20409337
DOI: 10.1186/1745-6215-11-42
PMCID: PMC2877028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20409337-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.PMID 20409337Read ↗

Update in the Management of Basal Cell Carcinoma.Semantic proximity Read ↗

Immunotherapy in the Management of Sinonasal Mucosal Melanoma: A Systematic Review.Semantic proximity Read ↗

TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study.Semantic proximity Read ↗

Mechanisms Underlying Imiquimod-Induced Regression of Basal Cell Carcinoma In VivoSemantic proximity Read ↗

[Histologic risk factors of basal cell carcinoma of the face, about 184 cases].Semantic proximity Read ↗

Image guidance improves freedom from recurrence in superficial radiation therapy for non-melanoma skin cancerSemantic proximity Read ↗

New therapeutic options for actinic keratosis and basal cell carcinoma.Semantic proximity Read ↗

Radiation sensitivity and efficacy in aggressive and non-aggressive basal cell carcinoma (BCC) of the skin: Image Guided Superficial Radiation Therapy achieves high rate of local control in sclerosing, infiltrative, morpheaform and micronodular BCC subtypes as well as in non high risk BCCs, an analysis of 7994 BCC lesionsSemantic proximity Read ↗

Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping.Semantic proximity Read ↗

SURGICAL ANALYSIS AND BIOLOGICAL BEHAVIOUR OF 2277 BASAL CELL CARCINOMASSemantic proximity Read ↗

Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.Semantic proximity Read ↗

Oral Baricitinib in the Treatment of Cutaneous Lichen PlanusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.